BeStock  
Markets › Compare › VIR vs KRSA

VIR vs KRSA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
VIR · Vir Biotechnology$8.39 ▼ 5.41%
KRSA · Korsana Biosciences$37.56 ▲ 5.95%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

51151250350450Nov 24, '25May 26, '26Nov 20, '26
  • VIR +37.1%
  • KRSA +260.1%

Head to head

MetricVIRKRSA
Price$8.39$37.56
Change today▼ 5.41%▲ 5.95%
Market cap$1.56B$1.71B
Return, 3 months-15.3%+36.5%
Return, year to date+39.1%+322.5%
Return, 1 year+47.7%+262.5%
P/E (TTM)––
P/B1.74.4
P/E percentile vs own 5y11th51st
Dividend yield––
Revenue growth (YoY, latest qtr)-207.7%–
Net profit growth (YoY)+41.0%-113.7%
Gross margin100.0%–
Operating margin-69.9%–
Net margin-61.1%–
Return on equity-21.8%-23.2%
Analyst target vs. price+167.3%+36.3%
Analyst buy share100%100%
RSI (14)3370
30-day volatility92.6%60.0%
Max drawdown, 1 year-38.5%-54.7%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • KRSA is the largest of the group by market value.
  • KRSA has returned the most over the past year.
  • KRSA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top